Ticker

No recent analyst price targets found for VYYRF.

Latest News for VYYRF

Voyageur Pharmaceuticals Announces the Engagement of Red Cloud Securities as Market Maker

Calgary, Alberta--(Newsfile Corp. - July 17, 2026) - Voyageur Pharmaceuticals Ltd. (TSXV: VM) (OTC Pink: VYYRF) ("Voyageur" or the "Company"), a Canadian developer of pharmaceutical-grade barium and iodine contrast media for medical imaging, is pleased to announce that it has engaged Red Cloud Securities Inc. ("Red Cloud"), subject to all required regulatory approvals, including the approval of the TSX Venture…

Newsfile Corp • Jul 17, 2026
Voyageur Pharmaceuticals Engages Fluor to Advance Feasibility Studies for Iodine Production and Integrated Contrast Drug Manufacturing Facility

CALGARY, Alberta – TheNewswire - June 23, 2026 – Voyageur Pharmaceuticals Ltd . ( TSX.V: VM ) (OTC Pink: VYYRF) (“ Voyageur ” or the “ Company ”), a Canadian developer of pharmaceutical-grade barium and iodine contrast media for medical imaging, is pleased to announce that it has engaged Fluor Corporation (“ Fluor ”), a leading global engineering, procurement, construction and maintenance firm, to complete…

TheNewswire • Jun 23, 2026
Voyageur Pharmaceuticals Evaluating Three Locations in the United States for Integrated Iodine and Barium Contrast Media Manufacturing Facility, a Multi-Phase Investment Expected to Generate Significant Economic Impact and High-Skilled Jobs; Competitive Site Selection Process Underway

CALGARY, Alberta – June 18, 2026 – TheNewswire - Voyageur Pharmaceuticals Ltd. (TSX-V: VM) (OTC Pink: VYYRF) (“Voyageur” or the “Company”), a Canadian developer of pharmaceutical-grade barium and iodine contrast media for medical imaging, is pleased to announce it is evaluating three potential locations in the United States for its planned integrated iodine and barium contrast drug manufacturing facility. The…

TheNewswire • Jun 18, 2026
Voyageur Pharmaceuticals Ltd. Submits Multi-Year Area-Based Exploration Permit Application for Bulk Sampling and Feasibility Support at Frances Creek Barite Project

Calgary, Alberta – TheNewswire - June 10, 2026 – Voyageur Pharmaceuticals Ltd. (TSX-V: VM) (the " Company " or " Voyageur ") announces the submission of a Multi-Year Area-Based (" MYAB ") Notice of Work (" NoW ") application to the British Columbia Ministry of Mining and Critical Minerals for its Frances Creek barite project. The application seeks authorization for a five-year advanced exploration program on a…

TheNewswire • Jun 10, 2026
Voyageur Announces Closing Of Non-Brokered Private Placement Pursuant To Listed Issuer Financing Exemption

Calgary, Alberta, Canada – June 5, 2026 – TheNewswire – Voyageur Pharmaceuticals Ltd. (TSX-V: VM) (the " Company " or " Voyageur "), a Canadian developer of pharmaceutical-grade barium and iodine for medical imaging contrast media, is pleased to announce that, further to its news releases dated May 1, 2026, and May 28, 2026, it has closed its non-brokered private placement (the " Offering "), and has issued (i)…

TheNewswire • Jun 5, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for VYYRF.

No Senate trades found for VYYRF.

No House trades found for VYYRF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top